Announcements

Amar K. Goel, Chairman and Chief Innovation Officer of PubMatic, Inc., filed a Form 4 on September 4, 2026, reporting transactions in Class A Common Stock dated September 3, 2026, on NASDAQ:PUBM.

Mark S. Livingston, Chief Financial Officer of Progyny, Inc. (NASDAQ:PGNY), filed a Form 4 on September 4, 2026, disclosing two disposals of common stock on September 2 and September 3, 2026, related to the vesting of restricted stock units.

Dane E. Holmes, Chief Administrative Officer of KKR & Co. Inc. (NYSE:KKR), filed a Form 4 on September 4, 2026, reporting the vesting of restricted holdings units and a subsequent sale of common stock on September 2 and 3, 2026.

Robert H. Lewin, Chief Financial Officer of KKR & Co. Inc. (NYSE:KKR), filed a Form 4 on September 4, 2026, disclosing a charitable donation of 10,000 shares of KKR common stock made on September 2, 2026.

Director Louise C. Forlenza filed a Form 4 with the SEC on September 4, 2026, reporting the exercise of two stock options and the sale of 10,000 shares of common stock in Innodata Inc. (NASDAQ:INOD) on the same date.

Joel Becker, Chief Executive Officer and Director of NeuroPace Inc., filed a statement of changes in beneficial ownership on September 4, 2026, reporting a transaction in NeuroPace common stock dated September 3, 2026.

Squadron Capital LLC filed a Form 4 with the SEC on September 4, 2026, disclosing the sale of 22,500 shares of OrthoPediatrics Corp common stock on September 2, 2026, at a weighted average price of $23.35 per share.